Investigational Drug Information for SHR0302
✉ Email this page to a colleague
What is the development status for investigational drug SHR0302?
SHR0302 is an investigational drug.
There have been 24 clinical trials for SHR0302.
The most recent clinical trial was a Phase 2 trial, which was initiated on April 30th 2021.
The most common disease conditions in clinical trials are Arthritis, Arthritis, Rheumatoid, and Eczema. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd., Reistone Biopharma Company Limited, and Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine.
There is one US patent protecting this investigational drug and twenty-seven international patents.
Summary for SHR0302
| US Patents | 1 |
| International Patents | 27 |
| US Patent Applications | 27 |
| WIPO Patent Applications | 9 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2021-04-30) |
| Vendors | 21 |
Recent Clinical Trials for SHR0302
| Title | Sponsor | Phase |
|---|---|---|
| To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma | Henan Cancer Hospital | Phase 1 |
| Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy Subjects | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
Clinical Trial Summary for SHR0302
Top disease conditions for SHR0302
Top clinical trial sponsors for SHR0302
US Patents for SHR0302
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| SHR0302 | ⤷ Try a Trial | Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof | Jiangsu Hengrui Medicine Co., Ltd. (Lianyungang, Jiangsu, CN) Shanghai Hengrui Pharmaceutical Co., Ltd. (Shanghai, CN) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for SHR0302
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| SHR0302 | Australia | AU2012357296 | 2031-12-21 | ⤷ Try a Trial |
| SHR0302 | Brazil | BR112014014325 | 2031-12-21 | ⤷ Try a Trial |
| SHR0302 | Canada | CA2857977 | 2031-12-21 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
